Pharmacokinetics of reboxetine in healthy, elderly volunteers

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 25, Issue 3-4, 2000, Pages 195-198

  Bergmann, J F ^a   Laneury, J P ^b   Duchene, P ^b   Fleishaker, J C ^c   Houin, G ^d   Segrestaa J M ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b ADME Bioanalyses SA   (France)

^c PFIZER INC   (United States)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Antidepressant; Elderly; Pharmacokinetics; Reboxetine; Volunteers

Indexed keywords

NORADRENALIN UPTAKE INHIBITOR; REBOXETINE;

AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG CLEARANCE; DRUG DETERMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG TOLERABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY CLEARANCE; MALE; VOLUNTEER;

ADRENERGIC UPTAKE INHIBITORS; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; HUMANS; MORPHOLINES;

EID: 0034438860     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03192313     Document Type: Article

References (9)

1. Reboxetine: Additional benefits to the depressed patient
2. Reboxetine: A review of antidepressant tolerability
3. Rationalizing antidepressants for elderly people
4. Pharmacokinetics of reboxetine in healthy volunteers: Single oral doses, linearity and plasma protein binding
5. Review of pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor
6. Cytochrome P450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes
7. Recent pharmacologic advances in antidepressant therapy for the elderly
8. Pharmacokinetic and pharmacodynamic principles of drug therapy in old age, Part 2
9. Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokinetics